We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
HAE

Price
71.08
Stock movement down
-0.47 (-0.86%)
Company name
Haemonetics Corporation
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Markedsværdi
2.60B
Ent værdi
3.95B
Pris/omsætning
1.91
Pris/bog
2.96
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
-
Efterfølgende P/E
21.00
Fremtidig P/E
10.95
PEG
-
EPS-vekst
17.09%
1 års afkast
-27.88%
3 års afkast
-10.90%
5 års afkast
-8.56%
10 års afkast
3.35%
Senest opdateret: 2025-09-12

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UDBYTTE

HAE betaler ikke udbytte

iO Charts is a Seeking Alpha partner

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E21.00
Pris til OCF30.62
Pris til FCF68.66
Pris til EBITDA11.72
EV i forhold til EBITDA17.80

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning1.91
Pris til egenkapital2.96
EV i forhold til salg2.90

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier48.18M
EPS (TTM)2.42
FCF pr. aktie (TTM)0.74

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)1.36B
Bruttofortjeneste (TTM)703.72M
Driftsindkomst (TTM)193.22M
Nettoindkomst (TTM)123.81M
EPS (TTM)2.42
EPS (1 år frem)4.93

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)51.70%
Driftsmargin (TTM)14.19%
Fortjenstmargin (TTM)9.10%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter299.28M
Nettotilgodehavender213.53M
Omsætningsaktiver i alt955.90M
Goodwill616.16M
Immaterielle aktiver487.84M
Ejendomme, anlæg og udstyr939.09M
Sum aktiver2.53B
Kreditor69.24M
Kortfristet/nuværende langsigtet gæld1.22B
Summen af kortfristede forpligtelser273.95M
Sum gæld1.65B
Aktionærernes egenkapital878.85M
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)84.94M
Investeringsudgifter (TTM)47.07M
Fri pengestrøm (TTM)37.88M
Udbetalt udbytte (TTM)0.00

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast14.09%
Afkast af aktiver4.90%
Afkast af investeret kapital5.89%
Kontant afkast af investeret kapital1.80%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning53.64
Daglig høj54.53
Daglig lav53.50
Daglig volumen738K
Højeste gennem alle tider139.48
1 års analytiker estimat78.64
Beta0.40
EPS (TTM)2.42
Udbytte pr. aktie-
Ex-div dato-
Næste dato for resultatpræsentation6 Nov 2025

Nedsidepotensial

Loading...
Nedsidepotensial-data
HAES&P500
Nuværende prisfald fra top notering-61.30%-1.46%
Højeste prisfald-68.62%-56.47%
Højeste efterår dato27 Jan 20229 Mar 2009
Gennemsnitlig fald fra toppen-23.14%-10.99%
Gennemsnitlig tid til nyt højdepunkt35 days12 days
Maks. tid til nyt højdepunkt1527 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

OPLYSNINGER OM VIRKSOMHEDEN
HAE (Haemonetics Corporation) company logo
Markedsværdi
2.60B
Markedsværdi kategori
Mid-cap
Beskrivelse
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. It also provides treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE closure products comprising VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, clinical specialists, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Personale
3023
Investor relationer
-
SEC-indsendelser
Adm. direktør
Christopher A. Simon
Land
USA
By
Boston
Aktietype
Common stock
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...

iO Charts is a Seeking Alpha partner

FORSTÅ FORRETNINGEN
Loading...